Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2025-12-24 @ 9:09 PM
NCT ID:
NCT04217304
Eligibility Criteria:
Inclusion Criteria:
* Patients presenting with STEMI within 6 hours of symptom onset and:
1. Are expected to receive reperfusion therapy with fibrinolysis
2. Have a high-risk STEMI ECG as defined as:
* \>2mm ST-segment elevation in 2 anterior or lateral leads; or
* \>2mm ST-segment elevation in 2 inferior leads coupled with ST-segment depression in 2 contiguous anterior leads for a total ST-segment deviation of \>4mm
3. Age \>30 years
4. Adequate apical and/or parasternal images by echocardiography
Exclusion Criteria:
* 1\. Isolated inferior STEMI without anterior ST-segment depression 2. Previous coronary bypass surgery 3. Cardiogenic shock 4. Known or suspected hypersensitivity to ultrasound contrast agent used for the study 5. Life expectancy of less than two months or terminally ill 6. Known bleeding diathesis or contraindication to glycoprotein 2b/3a inhibitors, anticoagulants, or aspirin 7. Known large right to left intracardiac shunts 8. Patient received another investigational medication or treatment within 30 days prior to presentation with STEMI
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04217304
Study Brief:
Protocol Section:
NCT04217304